In our study, CASP9 was also found to be negatively associated with stromal score and the infiltration of immunosuppressive cells such as MDSCs in GBM, implying that CASP9 may also exert anti‐tumour effects by regulating the TIME of GBM. The gene discussed is CASP9; the disease is glioblastoma.